Jerome Benedict Durso is CEO of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 102,825 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $1,953,675. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jerome Benedict Durso Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2023
SELL
Sale (or disposition) back to the issuer
$1,953,675 $19.0 p/Share
102,825 Reduced 100.0%
0 Common Stock
Nov 08 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$984,485 $19.0 p/Share
51,815 Reduced 100.0%
0 Common Stock
Jan 27 2023
BUY
Grant, award, or other acquisition
-
50,400 Added 24.58%
154,640 Common Stock
Dec 31 2022
SELL
Payment of exercise price or tax liability
$87,616 $12.37 p/Share
7,083 Reduced 6.36%
104,240 Common Stock
Jan 27 2022
BUY
Grant, award, or other acquisition
-
35,700 Added 24.28%
111,323 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$5,441 $16.29 p/Share
334 Reduced 0.44%
75,623 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$91,338 $16.29 p/Share
5,607 Reduced 6.87%
75,957 Common Stock
Oct 01 2021
SELL
Payment of exercise price or tax liability
$4,399 $15.22 p/Share
289 Reduced 0.35%
81,564 Common Stock
Jul 01 2021
SELL
Payment of exercise price or tax liability
$5,916 $20.47 p/Share
289 Reduced 0.35%
81,853 Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
$7,017 $24.28 p/Share
289 Reduced 0.35%
82,142 Common Stock
Feb 23 2021
SELL
Payment of exercise price or tax liability
$8,970 $28.12 p/Share
319 Reduced 0.39%
82,431 Common Stock
Jan 22 2021
BUY
Grant, award, or other acquisition
-
46,000 Added 35.73%
82,750 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$8,250 $24.7 p/Share
334 Reduced 0.9%
36,750 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$41,990 $24.7 p/Share
1,700 Reduced 4.38%
37,084 Common Stock
Nov 23 2020
SELL
Payment of exercise price or tax liability
$11,315 $35.47 p/Share
319 Reduced 0.82%
38,784 Common Stock
Oct 01 2020
SELL
Payment of exercise price or tax liability
$12,161 $42.08 p/Share
289 Reduced 0.73%
39,103 Common Stock
JBD

Jerome Benedict Durso

CEO
New York, NY

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Track Activities on ICPT